Medication info
Zadiglimmet Tablets 5/850 mg (Empagliflozin 2L-Proline, Metformin)

Zadiglimmet Tablets 5/850 mg (Empagliflozin 2L-Proline, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›7.56mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Yellowish-white, biconvex, oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202503024 · Approved 2025.11.19

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood sugar control
  • cardiovascular disease
  • cardiovascular events
View approved original text

This medication helps improve blood sugar control in adults with type 2 diabetes by combining empagliflozin and metformin. It can be used effectively along with dietary and exercise therapy to manage blood sugar. It is particularly applicable to patients with type 2 diabetes who have cardiovascular diseases and poor blood sugar control, in which case cardiovascular event precautions should be observed. This medication is used to improve treatment of diabetes and blood sugar management.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current metformin dose. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years and older, consider renal function and the risk of volume depletion.

Precautions

This medication is used for the treatment of diabetes and plays a role in lowering blood sugar. However, there are several precautions to be taken when using this medication. First, it should not be used in patients with impaired kidney function, severe infections, dehydration, or heart failure. Additionally, pregnant or breastfeeding women should not take this medication. This medication may cause hypoglycemia; therefore, special caution should be taken when used alongside insulin or other blood sugar-lowering medications. Regular kidney function tests should be performed during treatment, and if there are symptoms of dehydration or severe gastrointestinal disorders, the medication may be temporarily stopped. Also, it must be discontinued before and after using tests that involve iodine-based contrast agents and resumed only after kidney function has returned to normal. This medication can potentially cause serious side effects such as lactic acidosis, so medical advice should be sought immediately if unusual symptoms occur. Urinary tract infections or genital infections may occur; prompt treatment is necessary if infection symptoms arise. This medication may decrease vitamin B12 levels, so periodic vitamin B12 tests are recommended for long-term use. Alcohol consumption may increase the risk of lactic acidosis, thus excessive drinking should be avoided while on this medication. Elderly patients or those with reduced fluid volume need to be cautious of dehydration and low blood pressure, and should have their condition regularly checked. Lastly, regular follow-ups with a doctor are necessary while taking this medication, and any unusual symptoms should be reported immediately.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 112 more
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • pruritus
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • decreased fluid volume
  • ketosis
  • lactic acidosis
  • perineal necrosis
  • vulvovaginitis
  • balanitis
  • positional dizziness
  • headache
  • dizziness
  • insomnia
  • fever
  • asthenia
  • chest pain
  • hematuria
  • urinary stones
  • cervicitis
  • vulvar pruritus
  • genital pruritus
  • hyperglycemia
  • hyponatremia
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • angina
  • unstable angina
  • hypertension
  • anxiety
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • macular fibrosis
  • ocular discomfort
  • conjunctival congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • serous retinal detachment
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exercise-induced dyspnea
  • wet cough
  • allergic rhinitis
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • palpitations
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial obstructive disease
  • anxiety
  • depression
  • sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the medication's efficacy and safety over time.

Appearance and packaging

Appearance

Yellowish-white, biconvex, oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.